0

Journal Articles

in Percutaneous Coronary Intervention
 61-80 of 80 Articles
Review |  July 21, 2004 FREE
Early vs Late Administration of Glycoprotein IIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction:  A Meta-analysis
Gilles Montalescot, MD, PhD; Maria Borentain, MD; Laurent Payot, MD; et al.
JAMA. 2004;292(3):362-366. doi:10.1001/jama.292.3.362.
Original Contribution |  February 25, 2004 FREE
Early Administration of Reteplase Plus Abciximab vs Abciximab Alone in Patients With Acute Myocardial Infarction Referred for Percutaneous Coronary Intervention:  A Randomized Controlled Trial
Adnan Kastrati, MD; Julinda Mehilli, MD; Klaus Schlotterbeck, MD; et al.
JAMA. 2004;291(8):947-954. doi:10.1001/jama.291.8.947.
JAMA Patient Page |  February 11, 2004 FREE
Percutaneous Coronary Intervention
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2004;291(6):778. doi:10.1001/jama.291.6.778.
Editorial |  January 21, 2004
Ranolazine and Other Antianginal Therapies in the Era of the Drug-Eluting Stent
Peter Berger, MD
JAMA. 2004;291(3):365-367. doi:10.1001/jama.291.3.365.
Editorial |  February 19, 2003
Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?
Elliott M. Antman, MD
JAMA. 2003;289(7):903-905. doi:10.1001/jama.289.7.903.
Original Contribution |  February 19, 2003 FREE
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention:  REPLACE-2 Randomized Trial
A. Michael Lincoff, MD; John A. Bittl, MD; Robert A. Harrington, MD; et al.
JAMA. 2003;289(7):853-863. doi:10.1001/jama.289.7.853.
Original Contribution |  November 20, 2002 FREE
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention:  A Randomized Controlled Trial
Steven R. Steinhubl, MD; Peter B. Berger, MD; J. Tift Mann III, MD; et al.
JAMA. 2002;288(19):2411-2420. doi:10.1001/jama.288.19.2411.
Original Contribution |  August 28, 2002 FREE
Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention:  The Swiss Heart Study: A Randomized Controlled Trial
Guido Schnyder, MD; Marco Roffi, MD; Yvonne Flammer, MD; et al.
JAMA. 2002;288(8):973-979. doi:10.1001/jama.288.8.973.
Editorial |  June 26, 2002
Preventing Cardiac Events and Restenosis After Percutaneous Coronary Intervention
George Sopko, MD, MPH
JAMA. 2002;287(24):3259-3261. doi:10.1001/jama.287.24.3259.
Original Contribution |  June 26, 2002 FREE
Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention:  A Randomized Controlled Trial
Patrick W. J. C. Serruys, MD, PhD; Pim de Feyter, MD; Carlos Macaya, MD; et al.
JAMA. 2002;287(24):3215-3222. doi:10.1001/jama.287.24.3215.
Editorial |  April 17, 2002
Primary Percutaneous Coronary Intervention for All?
Christopher P. Cannon, MD
JAMA. 2002;287(15):1987-1989. doi:10.1001/jama.287.15.1987.
Original Contribution |  April 17, 2002 FREE
Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery:  A Randomized Controlled Trial
Thomas Aversano, MD; Lynnet T. Aversano, RN, BSN; Eugene Passamani, MD; et al.
JAMA. 2002;287(15):1943-1951. doi:10.1001/jama.287.15.1943.
Brief Report |  February 06, 2002 FREE
Long-term Efficacy of Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention
J. Conor O'Shea, MD; Christopher E. Buller, MD; Warren J. Cantor, MD; et al.
JAMA. 2002;287(5):618-621. doi:10.1001/jama.287.5.618.
Original Contribution |  January 09, 2002 FREE
Sex-Based Analysis of Outcome in Patients With Acute Myocardial Infarction Treated Predominantly With Percutaneous Coronary Intervention
Julinda Mehilli, MD; Adnan Kastrati, MD; Josef Dirschinger, MD; et al.
JAMA. 2002;287(2):210-215. doi:10.1001/jama.287.2.210.
Original Contribution |  July 04, 2001 FREE
Risk of Stroke Associated With Abciximab Among Patients Undergoing Percutaneous Coronary Intervention
K. Martijn Akkerhuis, MD; Jaap W. Deckers, MD; A. Michael Lincoff, MD; et al.
JAMA. 2001;286(1):78-82. doi:10.1001/jama.286.1.78.
Original Contribution |  May 16, 2001 FREE
Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention:  The ESPRIT Trial: A Randomized Controlled Trial
J. Conor O'Shea, MD; Gail E. Hafley, MS; Sally Greenberg, PhD; et al.
JAMA. 2001;285(19):2468-2473. doi:10.1001/jama.285.19.2468.
Original Contribution |  December 27, 2000 FREE
Relation Between Operator and Hospital Volume and Outcomes Following Percutaneous Coronary Interventions in the Era of the Coronary Stent
Paul D. McGrath, MD, MSc; David E. Wennberg, MD, MPH; John D. Dickens, Jr, MD; et al.
JAMA. 2000;284(24):3139-3144. doi:10.1001/jama.284.24.3139.
Original Contribution |  October 11, 2000 FREE
Differences in Prognostic Factors and Outcomes Between Women and Men Undergoing Coronary Artery Stenting
Julinda Mehilli, MD; Adnan Kastrati, MD; Josef Dirschinger, MD; et al.
JAMA. 2000;284(14):1799-1805. doi:10.1001/jama.284.14.1799.
Original Contribution |  March 01, 2000 FREE
Selective Referral to High-Volume Hospitals:  Estimating Potentially Avoidable Deaths
R. Adams Dudley, MD, MBA; Kirsten L. Johansen, MD; Richard Brand, PhD; et al.
JAMA. 2000;283(9):1159-1166. doi:10.1001/jama.283.9.1159.
Original Contribution |  July 28, 1999 FREE
Primary Coronary Angioplasty vs Thrombolysis for the Management of Acute Myocardial Infarction in Elderly Patients
Alan K. Berger, MD; Kevin A. Schulman, MD; Bernard J. Gersh, MB, ChB, DPhil; et al.
JAMA. 1999;282(4):341-348. doi:10.1001/jama.282.4.341.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  Oct 2012
Initial Experience With Hyperthermic Intraperitoneal Chemotherapy
Olivier Turrini, MD; Eric Lambaudie, MD; Marion Faucher, MD; et al.
JAMA Internal Medicine
Invited Commentary  |  Aug 13/27, 2012
How Drug-Eluting Stents Illustrate Our Health System's Flawed Relationship With Technology:  Comment on “Use of Drug-Eluting Stents as a Function of Predicted Benefit”
Peter W. Groeneveld, MD, MS
JAMA Internal Medicine
Original Investigation  |  Aug 13/27, 2012
Use of Drug-Eluting Stents as a Function of Predicted Benefit:  Clinical and Economic Implications of Current Practice
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
JAMA Internal Medicine
Editor's Correspondence  |  July 9, 2012
Percutaneous Coronary Intervention for Stable Coronary Artery Disease: The Debate Continues
Elvis A. Peter, MD; Nuri I. Akkus, MD; Jai Varma, MD, FSCAI
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems